The Manufacturing Steps

The production of cultivated meat relies on a biotechnological process that replicates natural cell growth. The process breaks down into four main steps:

Secondly, these cells are placed in bioreactors containing a culture medium that provides essential nutrients (amino acids, sugars, vitamins, mineral salts, growth factors). This controlled environment allows cells to multiply exponentially.

Thirdly, the culture medium is adapted to induce the differentiation of stem cells into muscle, fat, and connective cells, to obtain the texture and organoleptic properties of traditional meat.

Finally, these cells are organized into three-dimensional structures using edible scaffolds (proteins, polysaccharides) that serve as physical support and guide tissue formation, from minced meat or slices to pieces more closely resembling steaks or fillets.

Current Technical Challenges

Despite significant advances, cultivated meat production faces considerable technical challenges. The use of growth factors (such as fetal bovine serum or its synthetic alternatives) still represents a significant portion of costs. Research focuses on developing culture media without animal components, more affordable and ethically acceptable.

Potential Safety Advantages

Cultivated meat presents several potential advantages in terms of food safety. Produced in a controlled and sterile environment (bioreactor), it eliminates risks of contamination by fecal pathogens (E. coli, Salmonella, Campylobacter) or cross-contamination related to slaughter and cutting. It also avoids residues of veterinary drugs (antibiotics, antiparasitics) and health problems linked to intensive farming conditions. The industry relies on perfect traceability and food safety plans inspired by both the agri-food industry and pharmaceutical bioproduction.

Gray Areas and Potential Risks

Several questions nevertheless remain open. The use of immortalized cell lines (capable of dividing indefinitely) or induced pluripotent stem cells (iPS) requires rigorous characterization to rule out any risk of abnormal proliferation. The exact composition of culture media and potential presence of residues (antibiotics, antifungals used during production, growth factors) must be controlled. Finally, product stability and absence of microbial development throughout its shelf life must be guaranteed. Long-term toxicological studies and post-market surveillance will be essential to confirm the safety of these new processes.

Regulatory Evaluation in Europe

The European Union classifies cultivated meat in the "novel foods" category according to Regulation EU 2015/2283. To be commercialized, it must be authorized by the European Commission after a rigorous scientific evaluation by the European Food Safety Authority (EFSA). This evaluation covers in particular safety of use, nutritional value, and manufacturing processes. The first authorization request was submitted by the German start-up The Cultivated B in 2023. The complete evaluation process generally takes at least 18 to 24 months, suggesting possible first European authorizations from 2025-2026, subject to complete dossiers and favorable conclusions from EFSA.

Some member states have already taken strong political positions. Italy adopted a law in November 2023 prohibiting the production and commercialization of cultivated meat on its territory, invoking the protection of national agricultural and culinary heritage. This law is being discussed at European level regarding its compatibility with the principle of free movement of goods.

Composition and Nutritional Values

Cultivated meat aims to reproduce the nutritional composition of conventional meat. Its main asset is its content of high-quality proteins, with all essential amino acids, comparable to that of farmed meat. A notable advantage lies in the possibility of modulating its lipid composition during culture. It is theoretically possible to increase the proportion of beneficial polyunsaturated fatty acids (such as omega-3) and reduce that of saturated fatty acids, for a potentially more favorable lipid profile for cardiovascular health.

Identified Nutritional Deficiencies

However, cultivated meat currently presents several limitations. The production of myoglobin (iron-rich protein responsible for red color and contributing to iron intake) is complex to obtain in a bioreactor. Similarly, the natural synthesis or incorporation of vitamin B12, naturally produced by microorganisms in ruminants' digestive tracts, is not assured. These nutritional deficiencies will need to be compensated by enrichment of the culture medium or supplementation of the final product, which adds technical complexity and costs, and raises questions about regulation and communication to consumers.

Announced Environmental Benefits

Theoretically, cultivated meat could offer significant environmental advantages compared to conventional beef farming. Prospective studies (notably that published in 2022 by Sinke et al.) suggest potential significant reductions in land use (up to -95%), water consumption (-78%), and greenhouse gas emissions (-92%), if decarbonized electricity is used and production of culture medium ingredients is optimized. These ambitious figures form part of the industry's promises, even though they rely on future scenarios still very uncertain.

A More Complex Reality

More recent work has however nuanced this optimistic picture. A life cycle analysis (preprint from University of California, Davis, 2023) estimated that the carbon footprint of cultivated meat could, with current technologies and an average energy mix, be 4 to 25 times higher than that of conventional beef, mainly due to the high purity and energy required to produce culture medium ingredients. These results, still preliminary and debated, underline that environmental gains are not automatic and depend crucially on processes implemented at large scale, energy source, and design of less resource-intensive culture media.

Cost Evolution

The production cost of cultivated meat has dropped dramatically since the first burger presented in 2013 (estimated cost €250,000). Improvements in culture media (reduction or elimination of expensive fetal bovine serum), increased cell densities in bioreactors, and economies of scale have enabled this reduction. Companies in the sector now announce production costs in the order of a few tens of euros per kilogram for the simplest products (minced), and aim for parity with the retail price of premium meat by the end of the decade. However, these figures remain difficult to verify independently.

Global Market and Investments

Estimates of the size of the global cultivated meat market by 2030 vary considerably, ranging from a few hundred million to several billion dollars depending on study firms. The sector has attracted over $3 billion in investments since its beginnings. However, the actual trajectory will depend on several uncertain factors: speed of obtaining regulatory approvals in major markets (EU, China), evolution of energy costs, and final consumer perception and acceptance.

Public investments are concentrated mainly in the Netherlands, United Kingdom, Israel, and the United States, while countries like France and Italy adopt a more cautious, even restrictive position.

Public Reception

Acceptance of cultivated meat varies considerably by region, culture, and generation. Surveys generally show greater openness in Anglo-Saxon countries (USA, UK), Asia (Singapore, China), and among young urbanites, motivated by environmental, ethical, or technological curiosity considerations. In continental Europe, particularly in France, acceptance is more measured, linked to strong cultural attachment to culinary tradition, agriculture, and a certain distrust of foods perceived as "ultra-processed" or artificial. Debates around cultivated meat touch on cultural, identity, and political dimensions.

Communication Challenges

Terminology is a major perception issue. Terms like "cultured meat", "cell-based meat", or "cultivated meat" are preferred by the industry to evoke a controlled "cultivation" process, while "lab-grown meat" or "artificial meat", often used in media, convey a negative image of artificiality. Transparency about the process, benefits (safety, ecology), and guarantee of strict regulatory evaluation will be crucial to gain consumer trust.

Divergent National Positions in Europe

Europe presents a contrasted regulatory landscape. Italy has passed a law prohibiting production and commercialization of cultivated meat, invoking protection of food heritage. France, via its "France Nation Verte" plan, expresses reservations and favors other paths for protein transition (plant-based, legumes). Conversely, the Netherlands, United Kingdom, Germany, and Spain have allocated public funds to R&D in this field, positioning themselves as pioneers.

Regulations Outside EU and First Approved Products

Outside the European Union, two jurisdictions have already authorized commercialization of cultivated meat: Singapore (Eat Just's chicken in 2020, world first) and the United States (UPSIDE Foods and GOOD Meat chicken approved by FDA and USDA in 2023). Israel has also given its regulatory green light. These authorizations come with strict conditions (labeling, monitoring). Other countries like Canada, United Kingdom, China, and Australia have evaluation processes underway. These first market launches, although confidential (selected restaurants), mark the beginning of commercialization of this new food category.

Animal Welfare and Agricultural Impact

Beyond technical, safety, and environmental aspects, cultivated meat raises complex ethical and societal questions. The central argument in its favor is the potential reduction of animal suffering, by eliminating farming and slaughter. However, the historical use of fetal bovine serum (FBS) – obtained by cardiac puncture on a bovine fetus – posed a serious ethical paradox. Most companies now claim to have developed or are developing culture media without FBS.

Recommendations for Consumers

Adopt an Informed and Nuanced Approach

Faced with this emerging innovation, consumers should adopt a critical and informed approach. It is important to distinguish marketing promises from scientific data verified by health authorities. Environmental benefits, although potentially significant, depend on technical and energy parameters still uncertain at scale.

Consider the Diversity of Solutions

Cultivated meat is only one option among others to reduce the environmental impact of food. Reducing meat consumption, choosing meat from sustainable farming, and increasing the share of plant proteins represent complementary alternatives, available today.

Remain Vigilant on Nutritional and Regulatory Aspects

Future consumers of cultivated meat should pay attention to its final nutritional composition (enrichment in iron, B12) and clear labeling, ensuring transparent information. Compliance with the EU's strict regulatory framework, once established, will be a guarantee of safety.